LPS, also named as endotoxin, was identified as a diagnostic biomarker for NAFLD, which can interact with its receptor TLR4 in inflammatory cells (e.g., macrophages and platelets) to initiate inflammatory processes and augment NAFLD susceptibility (92). This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.